Just to take Vaxxinia to end of phase 2 will cost $22.5m for patient cost alone. $4.5m for cohort of 30 in phase 1. Then $18m for cohort of 100-120 in phase1/2. CheckVacc has another 15-20 patients going into phase 1 ($3m cost).
The amount that is riding on the hervaxx data readout is enormous for shareholders.
Ann: Appendix 4C - quarterly, page-44
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.002(2.88%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $283.1K | 5.381M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 1257320 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 2003839 | 24 |
View Market Depth
| Last trade - 15.52pm 27/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |